scholarly journals Characteristics of mastoid carcinoma at Otorhinolaryngology Head and Neck Surgery Departement in dr. Zainoel Abidin General Hospital Banda Aceh

2021 ◽  
Vol 51 (1) ◽  
Author(s):  
Benny - Kurnia ◽  
Baluqia Iskandar Putri
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Stage Iv ◽  
Neck Surgery ◽  
Head And Neck Surgery ◽  
Stage Iii ◽  
Histopathological Type ◽  
Banda Aceh

Background: Mastoid carcinoma is a rare case and an aggressive tumor with a poor prognosis. Purpose: To identify the characteristics of mastoid carcinoma in Otorhinolaryngology Head and Neck Surgery Department of dr. Zainoel Abidin Banda Aceh. Method: This study was a descriptive study using medical records data of dr. Zainoel Abidin Hospital Banda Aceh from January 2012 to July 2019 and from the histopathological data as a confirmation. Result: There were 9 cases consisted of 44% male and 56% female with the ratio 1:1,2, in which 41-60 year old were the majority of the patients. Clinical symptoms obtained are otalgia (100%), otorrhea (100%), discharge (100%), facial parental (100%), hearing loss (100%), ear canal mass (100%) and retroauricular mass (44, 4%). The histopathological type of all cases was Squamous Cell Carcinoma (100%). Stage IV of 55.6% and stage III of 44.4% were determined based on CT Scan. Chemotherapy was performed in 89% of patients and 11% of radiotherapy patients. Conclusion: The comparison of male and female mastoid carcinomas is 1:1,2 with a peak incidence at 41-60 years. The histopathological type of all patients was Squamous Cell Carcinoma and based on CT scans found 55.6% of stage IV patients and 44.4% of stage III patients. Chemotherapy was performed in 89% of patients and 11% of radiotherapy patients.

Simultaneous combination radiotherapy and multidrug chemotherapy for stage III and stage IV squamous cell carcinoma of the head and neck

1980 ◽  
Vol 15 (1) ◽  
pp. 91-98 ◽  
Author(s):  
Bert L. Smith ◽  
Jerry L. Franz ◽  
Joaquin G. Mira ◽  
George A. Gates ◽  
J. Sapp ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Stage Iv ◽  
Stage Iii ◽  
Multidrug Chemotherapy

Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study.

1988 ◽  
Vol 6 (4) ◽  
pp. 627-632 ◽  
Author(s):  
M Merlano ◽  
R Rosso ◽  
M R Sertoli ◽  
L Bonelli ◽  
G Margarino ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Randomized Study ◽  
Stage Iv ◽  
Phase Iii ◽  
Stage Iii ◽  
Definitive Treatment ◽  
Response Analysis

A cooperative randomized study was begun in August 1983 to compare a sequential program of induction chemotherapy followed by definitive treatment, arm A, with an alternation of chemotherapy and radiotherapy (three courses of 20 Gy in ten daily fractions), arm B. The same chemotherapy was used in both arms: 6 mg/m2, vinblastine, hour 0; 30 mg, bleomycin, hour 6; 200 mg, methotrexate, hours 24 to 26; 45 mg, leucovorin, hour 48. One hundred sixteen patients entered the study, 55 in arm A and 61 in arm B. The patients all had previously untreated squamous cell carcinoma of the head and neck (SCCHN). Forty-five patients had stage III and 71 had stage IV disease. The two arms were fully comparable. As of April 1986, 116 patients were evaluable for survival, while 112 were evaluable for toxicity and 105 for response. Response analysis shows that there were 14 complete responses (CR) and 11 partial responses (PR), for an overall response rate (ORR) of 52% in arm A, and 30 CRs and seven PRs, for an ORR of 64.9% in arm B. The difference in terms of CR between the two arms was statistically significant (P less than .03). Progression-free survival (PFS) was also statistically different, with an advantage for arm B (P less than .05), but without differences in overall survival. Arm B correlates with a significant increase in mucositis compared with arm A (P less than .001).

scholarly journals Clinicopathological profile of squamous cell carcinoma presenting in Tertiary Care Hospital, Karachi.

2020 ◽  
Vol 27 (05) ◽  
pp. 939-943
Author(s):  
Sameera Asif ◽  
Summera Kanwal ◽  
Tahera Ayub ◽  
Zafar Abbas ◽  
Batool Vazir ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Buccal Mucosa ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Stage Iv ◽  
Stage Ii ◽  
Stage Iii ◽  
Care Hospital

Objectives: Oral Squamous cell carcinoma (OSCC) is the most common malignant tumor of the oral cavity. The study was done with the aim to determine the clinical pattern of OSCC seen in tertiary care hospital of Karachi, Pakistan. The frequency of neck metastasis in different staging of squamous cell carcinoma was also recorded. Study Design: Retrospective study. Setting: Department of Oral & Maxillofacial Surgery Liaquat College of Medicine and Dentistry. Period: June 2013- July 2016. Material & Methods: It included 35 males and 25 females which presented with different sites and stage of squamous cell carcinoma. Clinically patients were staged as stage I, stage II, stage III and stage IV and comprised of 3, 8, 30 & 19 patients respectively. Patients presented with cancer of buccal mucosa (31 patients), retromolar region (12 patients), maxillary alveolus (8 patients), tongue (2 patients), floor of mouth (4 patients) & lip (3 patients). Right side was most common, 48 patients as compare to left side, 12 patients while lip cancers was in upper lip in all patients including commissure. Results: Total 60 patients were included in the study with the male to female ratio of 1.4:1. No significant association was seen between age and gender of the patient (p-value 0.933). Majority of patients were male involving buccal mucosa (51.67%) as the most frequently involved site followed by retromolar area (20%) and tongue (13.3%). Mean age of patients included in the study was 50.87 ± 5.53. Conclusion: Most of the cases of OSCC were seen in older patients with increased number of cases involving buccal mucosa as their primary site. Majority of the tumors were classified as stage III followed by Stage IV, Stage II and stage 1 respectively.

scholarly journals Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck

2004 ◽  
Vol 15 (4) ◽  
pp. 646-652 ◽  
Author(s):  
M. Benasso ◽  
R. Corvò ◽  
A. Ponzanelli ◽  
G. Sanguineti ◽  
I. Ricci ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Stage Iv ◽  
Gemcitabine And Cisplatin

Concurrent chemoradiotherapy (crt) with weekly docetaxel (d) for advanced head and neck cancer

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 15516-15516
Author(s):  
G. López-Argumedo ◽  
G. López-Vivanco ◽  
R. Fernández ◽  
I. Díaz de Corcuera ◽  
A. Sancho ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Head And Neck Cancer ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Neck Cancer ◽  
Squamous Cell ◽  
Response Rate ◽  
Stage Iii ◽  
Advanced Head ◽  
Percutaneous Gastrostomy

15516 Background: Concomitant CRT has become a standard treatment for advanced head and neck cancer. The aim of this study was to evaluate the efficacy and toxicity of concurrent CRT with D in patients (pts) with advanced squamous cell carcinoma of head and neck (SCCHN). Methods: Patients with untreated and unresectable stage III or IV (M0) squamous cell carcinoma of head and neck were included. Treatment consisted of D 20 mg/m2 weekly with concomitant radiotherapy 70 Gy (2 Gy per day, 7 weeks). Results: From September 03 to October 05, sixty-four pts with advanced SCCHN, were recruited. Gender: 61 male, 3 female. Mean age: 56.5 years old (range 42–77). ECOG PS 0/1/2: 0/57/7. Primary sites of disease: oral cavity 8, oropharynx 26, hypopharynx 15 and larynx 15. Stage III 16 pts and stage IV 48 pts. Compliance: 393 administrations of D were given, median 6, mean 6 (range 1–8). Fifty-five pts (86%) completed the radiotherapy dose planned (mean dose of RT was 66 Gy). One refused more treatment with D after first administration. Nineteen pts required supportive percutaneous gastrostomy or nasogastric tubes previously or during therapy. Grade 2/3/4 toxicity per patient: anemia 4/2/0, mucositis 21/24/0, dermatitis 21/20/0. Neither thrombopenia nor neutropenia were observed. Four pts died of aspiration pneumonia during treatment, one of gastric perforation and two of unknown causes. Fifty-six pts were evaluable for response: CR 28 (44%), PR 23 (36%), SD 2 (3%), PD 3 (5%), with an overall response rate of 80%. Median overall survival was 74.86 weeks (95% CI: 40.40–109.32) and median progression free survival was 48 weeks (95% CI: 18.80–77.20). With a median follow up of 40 weeks 34 pts (53%) were alive and 21 of them (33%) remained free of disease. Conclusions: Concurrent weekly D with conventional radiotherapy showed a high response rate. Toxicity was manageable and allowed maintaining radiotherapy administration. Taking into account poor prognostic factors of our series, survival results seem promising. No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document